Study: Artificial Intelligence Can Predict Risk of Recurrence for Women With Common Breast Cancer
October 15th 2021They added that this is one of the first proofs of concept illustrating the power of an AI model for identifying parameters associated with relapse that the human brain could not detect.
Read More
Pharmacy Focus Episode 33: American Pharmacists Month 2021
October 15th 2021A panel overview of the important topics happening in pharmacy, such as the role of technicians growing in the field, COVID-19’s impact on their work, and what they feel the value of a pharmacist is. Happy American Pharmacists Month!
Listen
Clinical Development Program Shows Promise for Microbiome-Based Therapeutics in Recurrent C. Diff
October 14th 2021Lindy Bancke, PharmD, head of clinical development at Rebiotix Inc, said the clinical development program of RBX2660 is showing promise in the treatment of recurrent C. Difficile infection.
Watch
Iowa's Drug Disposal Program Designed for Positive Impact on Opioid Epidemic
October 13th 2021In an interview with Pharmacy Times®, Mitchell Barnett, PharmD, MS, associate director of the Iowa Prescription Monitoring Program for the Iowa Board of Pharmacy, and Mylo Wells, PharmD, owner of Wells Hometown Drug, discuss Iowa’s new drug disposal kit program and the impact it could have on the opioid epidemic.
Watch
According to Ocular Therapeutix, Dextenza is now the first FDA-approved, physician-administered intracanalicular insert capable of delivering a preservative-free drug for the treatment of ocular itching associated with allergic conjunctivitis with a single administration for up to 30 days.
Read More